| The Association Of A Sweetened Beverage Tax With Changes In Beverage Prices And Purchases At Independent Stores: Study compares changes in sweetened beverage prices and … SN Bleich, HG Lawman, MT LeVasseur, J Yan, N Mitra, CM Lowery, ... Health Affairs 39 (7), 1130-1139, 2020 | 54 | 2020 |
| Subgroups of high-cost Medicare advantage patients: an observational study BW Powers, J Yan, J Zhu, KA Linn, SH Jain, JL Kowalski, AS Navathe Journal of general internal medicine 34, 218-225, 2019 | 37 | 2019 |
| Unemployment claims in Philadelphia one year after implementation of the sweetened beverage tax HG Lawman, SN Bleich, J Yan, MT LeVasseur, N Mitra, CA Roberto PloS one 14 (3), e0213218, 2019 | 35 | 2019 |
| Applying machine learning algorithms to segment high-cost patient populations J Yan, KA Linn, BW Powers, J Zhu, SH Jain, JL Kowalski, AS Navathe Journal of general internal medicine 34, 211-217, 2019 | 34 | 2019 |
| Association of a Sweetened Beverage Tax With Purchases of Beverages and High-Sugar Foods at Independent Stores in Philadelphia SN Bleich, CG Dunn, MJ Soto, J Yan, LA Gibson, HG Lawman, N Mitra, ... JAMA Network Open 4 (6), e2113527-e2113527, 2021 | 31 | 2021 |
| One-year changes in sugar-sweetened beverage consumers’ purchases following implementation of a beverage tax: a longitudinal quasi-experiment HG Lawman, SN Bleich, J Yan, SV Hua, CM Lowery, A Peterhans, ... The American Journal of Clinical Nutrition 112 (3), 644-651, 2020 | 29 | 2020 |
| Effect of Patient Financial Incentives on Statin Adherence and Lipid Control: A Randomized Clinical Trial I Barankay, PP Reese, ME Putt, LB Russell, G Loewenstein, D Pagnotti, ... JAMA Network Open 3 (10), e2019429-e2019429, 2020 | 23 | 2020 |
| No Evidence of Food or Alcohol Substitution in Response to a Sweetened Beverage Tax LA Gibson, HG Lawman, SN Bleich, J Yan, N Mitra, MT LeVasseur, ... American journal of preventive medicine 60 (2), e49-e57, 2021 | 22 | 2021 |
| Sustained Impact of the Philadelphia Beverage Tax on Beverage Prices and Sales Over 2 Years J Petimar, LA Gibson, J Yan, SN Bleich, N Mitra, ML Trego, HG Lawman, ... American journal of preventive medicine 62 (6), 921-929, 2022 | 19 | 2022 |
| 3-Year Follow-up Analysis of ZUMA-5: A Phase 2 Study of Axicabtagene Ciloleucel (Axi-Cel) in Patients with Relapsed/Refractory (R/R) Indolent Non-Hodgkin Lymphoma (iNHL) SS Neelapu, J Chavez, AR Sehgal, N Epperla, M Ulrickson, E Bachy, ... Blood 140 (Supplement 1), 10380-10383, 2022 | 17 | 2022 |
| Effect of Escalating Financial Incentive Rewards on Maintenance of Weight Loss: A Randomized Clinical Trial WS Yancy, PA Shaw, C Reale, V Hilbert, J Yan, J Zhu, AB Troxel, ... JAMA network open 2 (11), e1914393-e1914393, 2019 | 17 | 2019 |
| The Beneficial Effects Of Medicare Advantage Special Needs Plans For Patients With End-Stage Renal Disease: Study compares use and costs for patients with end-stage renal … BW Powers, J Yan, J Zhu, KA Linn, SH Jain, J Kowalski, AS Navathe Health Affairs 39 (9), 1486-1494, 2020 | 16 | 2020 |
| Countermarketing About Fruit Drinks, Alone or With Water Promotion: A 2019 Randomized Controlled Trial in Latinx Parents J Krieger, T Kwon, R Ruiz, LP Walkinshaw, J Yan, CA Roberto American journal of public health 111 (11), 1997-2007, 2021 | 11 | 2021 |
| The Habit Formation trial of behavioral economic interventions to improve statin use and reduce the risk of cardiovascular disease: Rationale, design and methodologies ME Putt, PP Reese, KG Volpp, LB Russell, G Loewenstein, J Yan, ... Clinical Trials 16 (4), 399-409, 2019 | 11 | 2019 |
| A machine learning approach to identify distinct subgroups of veterans at risk for hospitalization or death using administrative and electronic health record data RB Parikh, KA Linn, J Yan, ML Maciejewski, AM Rosland, KG Volpp, ... PloS one 16 (2), e0247203, 2021 | 10 | 2021 |
| Qualitative Exploration of Barriers to Statin Adherence and Lipid Control: A Secondary Analysis of a Randomized Clinical Trial I Barankay, PP Reese, ME Putt, LB Russell, C Phillips, D Pagnotti, ... JAMA Network Open 4 (5), e219211-e219211, 2021 | 8 | 2021 |
| Real-World Outcomes of Brexucabtagene Autoleucel (Brexu-cel) for Relapsed or Refractory (R/R) Mantle Cell Lymphoma (MCL): A CIBMTR Subgroup Analysis of High-Risk Characteristics S Kambhampati, N Ahmed, M Hamadani, S Kim, MT Hemmer, NS Grover, ... Blood 142, 107, 2023 | 3 | 2023 |
| Purchases of Non-taxed Foods, Beverages, and Alcohol in a Longitudinal Cohort after Implementation of the Philadelphia Beverage Tax AH Grummon, CA Roberto, HG Lawman, SN Bleich, J Yan, N Mitra, ... The Journal of nutrition, 2021 | 3 | 2021 |
| An Updated Comparison of Clinical Outcomes from 4-Year Follow-up of Zuma-5 (Axicabtagene Ciloleucel) and the International Scholar-5 External Control Cohort in Relapsed … JG Gribben, P Ghione, ML Palomba, MD Ray, EH Limbrick-Oldfield, ... Blood 142, 4869, 2023 | 2 | 2023 |
| 3-Year Follow-up Analysis of Zuma-5: A Phase 2 Study of Axicabtagene Ciloleucel (Axi-Cel) in Patients (Pts) with Relapsed/Refractory (R/R) Indolent Non-Hodgkin Lymphoma (iNHL) SS Neelapu, JC Chavez, AR Sehgal, N Epperla, ML Ulrickson, E Bachy, ... 2023 Tandem Meetings| Transplantation & Cellular Therapy Meetings of ASTCT …, 2023 | 2 | 2023 |
